This 1-page flow-chart developed by the University of Liverpool in collaboration with ASHM and INHSU outlines simple steps to follow after identifying potential drug-drug interactions involving hepatitis C direct acting antiviral (DAA) regimens.
Primary care providers can confidently determine when and how to proceed with DAA treatment after consulting this resource. The drug-drug interactions checker website can be found here.
This resource was published more than two years ago. Some information may be outdated or may not reflect current clinical evidence and guidelines. Please direct any queries to [email protected]